Form 4 for CNMD CONMED Corp
Accepted 2023-05-02 00:00:00 ET · period of report 2023-04-28 · accession 0001127602-23-014093 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-05-02 | 2023-04-28 | CNMD | Pelletier Johonna Marie | VP, Treas, Tax | S - Sale+OE | $126.38 | -24.0K | 22.0K | -52% | -$3.04M |
| DM | 2023-05-02 | 2023-04-28 | CNMD | Pelletier Johonna Marie | VP, Treas, Tax | M - OptEx | $84.56 | +22.7K | 4,634 | New | +$1.92M |
| DM | 2023-05-02 | 2023-04-28 | CNMD | Pelletier Johonna Marie | VP, Treas, Tax | M - OptEx | $0.00 | -22.7K | 7,200 | -76% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-28 | S | D | 5,400 | $126.43 | 16,617 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.17 to $126.72. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 2 | Common | Common Stock | 2023-04-28 | S | D | 5,400 | $126.18 | 11,217 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.17 to $126.42. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 3 | Common | Common Stock | 2023-04-28 | S | D | 5,100 | $126.37 | 6,117 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.08 to $126.47. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 4 | Common | Common Stock | 2023-04-28 | S | D | 4,800 | $126.33 | 1,317 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.27 to $126.60. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 5 | Common | Common Stock | 2023-04-28 | M | A | 4,800 | $122.55 | 25,334 | D | — | — | |
| 6 | Common | Common Stock | 2023-04-28 | S | D | 1,317 | $127.06 | 24,017 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.01 to $127.18. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 7 | Common | Common Stock | 2023-04-28 | M | A | 5,400 | $59.96 | 10,034 | D | — | — | |
| 8 | Common | Common Stock | 2023-04-28 | M | A | 5,400 | $78.76 | 15,434 | D | — | — | |
| 9 | Common | Common Stock | 2023-04-28 | M | A | 5,100 | $97.69 | 20,534 | D | — | — | |
| 10 | Common | Common Stock | 2023-04-28 | S | D | 2,000 | $126.45 | 22,017 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.44 to $126.63. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder |
| 11 | Common | Common Stock | 2023-04-28 | M | A | 2,000 | $41.93 | 4,634 | D | — | — | |
| 12 | Derivative | Options To Purchase Common Stock | 2023-04-28 | M | D | 2,000 | $0.00 | 0 | D | $41.93 · — to 2027-03-01 | 2,000 Common Stock | (F7) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |
| 13 | Derivative | Options To Purchase Common Stock | 2023-04-28 | M | D | 5,400 | $0.00 | 0 | D | $59.96 · — to 2028-03-01 | 5,400 Common Stock | (F7) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |
| 14 | Derivative | Options To Purchase Common Stock | 2023-04-28 | M | D | 5,400 | $0.00 | 2,700 | D | $78.76 · — to 2029-03-01 | 5,400 Common Stock | (F8) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
| 15 | Derivative | Options To Purchase Common Stock | 2023-04-28 | M | D | 5,100 | $0.00 | 5,100 | D | $97.69 · — to 2030-03-02 | 5,100 Common Stock | (F8) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
| 16 | Derivative | Options To Purchase Common Stock | 2023-04-28 | M | D | 4,800 | $0.00 | 7,200 | D | $122.55 · — to 2031-03-01 | 4,800 Common Stock | (F8) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |